Newborn screening programs for metabolic disorders using tandem mass spectrometry are widely used. Medium Chain Acyl coA dehydrogenase deficiency (MCADD) is the most prevalent mitochondrial fatty acid oxidation defect and it has been proven that early detection of this metabolic disease decreases mortality and improves the outcome. In previous studies, data mining methods on derivatized tandem MS datasets, have shown high classification accuracies. However, no machine learning methods currently have been applied to datasets based on non-derivatized screening methods.
